Lowey Dannenberg, P.C. and Bursor & Fisher, P.A., Announce a Proposed Class Action Settlement If You Are Located in the United States and Used Any Website, App or Service Through GoodRx Holdings, Inc. at Any Time Prior to April 20, 2024

WHITE PLAINS, N.Y.--(BUSINESS WIRE)--Lowey Dannenberg, P.C.:

SUMMARY NOTICE OF PROPOSED CLASS ACTION SETTLEMENT

If you are located in the United States and used any website, app, or service made available by or through GoodRx Holdings, Inc. (“GoodRx”) at any time prior to April 20, 2024, your rights may be affected by a pending class action settlement and you may be entitled to a portion of the settlement fund.

This Summary Notice is to alert Settlement Class Members to a proposed $32,000,000 settlement with GoodRx and Criteo Corp. (“Criteo”) in the action titled Doe, et al. v. GoodRx Holdings, Inc., et al., Case No. 4:23-cv-00501-AMO (N.D. Cal.). Plaintiffs entered into the Settlement Agreement with GoodRx and Criteo on November 19, 2025.

What is this lawsuit about and what does the Settlement provide?

GoodRx is a combination telehealth and prescription coupon company that provides millions of people with telehealth services, coupons for prescription medication, and other health-related services each month. When people use GoodRx’s services, GoodRx collects their personal and health information, including information about their prescription medications and health conditions, email addresses, and phone numbers. Plaintiffs allege that between at least 2017 and 2020, GoodRx disclosed this sensitive personal and health information to advertising and analytics companies, including Criteo, Meta Platforms, Inc. (f/k/a Facebook, Inc.) (“Meta”) and Google LLC (“Google” and with Meta, “Remaining Defendants”) through GoodRx’s incorporation of the Criteo and Remaining Defendants’ technologies (i.e., software development kits (“SDKs”) and JavaScript pixels (“Pixels”)) on the GoodRx platform. Such disclosed data included any data or information related to a Person’s use of websites, applications, or services made available by or through GoodRx, including GoodRx’s website and app, GoodRx Gold, HeyDoctor, and GoodRx Care, and including but not limited to data or information that is or could be used, whether on its own or in combination with other information, to identify, locate, recognize, reach, or contact a person or device. Plaintiffs also allege that Remaining Defendants and Criteo used this information for their own purposes.

Plaintiffs allege that this conduct violated state wiretapping statutes, consumer and healthcare protection laws, common law and statutory privacy rights, laws prohibiting unfair business practices, and was negligent and unjustly enriched GoodRx, Criteo, and the Remaining Defendants. The lawsuit seeks compensation for people whose personal information was disclosed by these practices. GoodRx and Criteo dispute Plaintiffs’ allegations, deny that they violated any law, and maintain that they have good and meritorious defenses to Plaintiffs’ claims and would prevail if the case were to proceed.

To avoid the expense and uncertainty of further litigation, GoodRx and Criteo have agreed to pay $32,000,000 to resolve the Settlement Class’s claims. If the Settlement is approved, each Authorized Claimant will receive an equal (pro rata) share of the Settlement Fund after taxes, fund costs, administration and notice costs, court-awarded attorneys’ fees and expenses, service awards, and other costs or awards are deducted. If the Settlement is approved, the action will be resolved against GoodRx and Criteo, and Plaintiffs will continue to pursue their claims against the Remaining Defendants. If the Settlement is not approved, the action will continue against GoodRx, Criteo, and the Remaining Defendants.

Who is a member of the Settlement Class?

Subject to certain exceptions, the proposed Settlement Class consists of all natural persons in the United States who used any website, app, or service made available by or through GoodRx at any time prior to April 20, 2024.

The other capitalized terms used in this Summary Notice are defined in the detailed Notice of Proposed Class Action Settlement, February 11, 2027 Final Approval Hearing Thereon, and Settlement Class Members’ Rights (“Notice”) and the Amended Class Action Settlement Agreement and Release (“Settlement Agreement”). If you are not sure whether you are included in the Settlement Class, you can get more information, including the detailed Notice and the Settlement Agreement, at www.goodrxprivacysettlement.com or by calling toll-free 1-877-888-9232.

Who represents me?

The United States District Court for the Northern District of California (the “Court”) authorized this Summary Notice and has appointed the lawyers listed below to represent the Settlement Class in this action (“Class Counsel”):

Christian Levis Amanda Fiorilla Rachel Kesten LOWEY DANNENBERG, P.C. 44 South Broadway, Suite 1100 White Plains, NY 10601 Telephone: [phone]

L. Timothy Fisher Jenna L. Gavenman BURSOR & FISHER, P.A. 1990 North California Blvd., 9th Floor Walnut Creek, CA 94596 Telephone: [phone]

If you want to be represented by your own lawyer, you may hire one at your expense.

Will I get a payment?

If you are a member of the Settlement Class and do not opt out, you may be eligible for a payment under the Settlement if you file a Claim Form. Claim Forms must be postmarked by December 29, 2026 or submitted online at www.goodrxprivacysettlement.com on or before 11:59 p.m. Eastern Time on December 29, 2026.

What are my rights?

If you are a Settlement Class Member and do not opt out, you will release certain legal rights against GoodRx and Criteo as explained in the detailed Notice and Settlement Agreement, which are available at www.goodrxprivacysettlement.com. If you do not want to take part in the proposed Settlement, you must opt out by December 29, 2026. You may object to the proposed Settlement and Class Counsel’s requests for attorneys’ fees and litigation expenses and service awards. If you want to object, you must do so by December 29, 2026. Information on how to opt out or object is contained in the detailed Notice.

When is the Fairness Hearing?

The Court will hold the Fairness Hearing on February 11, 2027, at 11:00 a.m., at the United States District Court for the Northern District of California, Oakland Courthouse, 1301 Clay Street, Oakland, CA 94612, to consider whether to finally approve the proposed Settlement, the application for an award of attorneys’ fees and litigation expenses, and the application for service awards for Plaintiffs. The Fairness Hearing may be moved to a different date or time without notice to you. The Fairness Hearing may be conducted remotely. Although you do not need to attend, if you plan to do so, you should check the Settlement Website or the Court’s Public Access to Court Electronic Records (PACER) system at https://ecf.cand.uscourts.gov before making travel plans.

You or your lawyer may ask to appear and speak at the hearing at your own expense, but you do not have to. Any changes to the time and place of the Fairness Hearing, or other deadlines, will be posted to www.goodrxprivacysettlement.com as soon as is practicable.

For more information, call toll-free 1-877-888-9232 or visit www.goodrxprivacysettlement.com.